Arrowstreet Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-721,200
| Closed | -$88.5M | – | 1951 |
|
|
2025
Q4 | $88.5M | Buy |
721,200
+62,544
| +9% | +$7.6M | 0.05% | 316 |
|
|
2025
Q3 | $73.1M | Buy |
658,656
+232,072
| +54% | +$26.4M | 0.05% | 364 |
|
|
2025
Q2 | $47.3M | Buy |
426,584
+372,596
| +690% | +$39.7M | 0.03% | 436 |
|
|
2025
Q1 | $6.05M | Sell |
53,988
-85,618
| -61% | -$8.83M | ﹤0.01% | 968 |
|
|
2024
Q4 | $12.9M | Sell |
139,606
-2,857,063
| -95% | -$257M | 0.01% | 745 |
|
|
2024
Q3 | $251M | Sell |
2,996,669
-1,588,535
| -35% | -$121M | 0.21% | 95 |
|
|
2024
Q2 | $315M | Sell |
4,585,204
-461,229
| -9% | -$30.8M | 0.28% | 85 |
|
|
2024
Q1 | $370M | Sell |
5,046,433
-3,331,941
| -40% | -$256M | 0.34% | 68 |
|
|
2023
Q4 | $679M | Sell |
8,378,374
-1,839,296
| -18% | -$143M | 0.71% | 27 |
|
|
2023
Q3 | $766M | Buy |
10,217,670
+1,330,560
| +15% | +$102M | 0.93% | 23 |
|
|
2023
Q2 | $685M | Buy |
8,887,110
+695,909
| +8% | +$55.5M | 0.83% | 21 |
|
|
2023
Q1 | $680M | Sell |
8,191,201
-24,833
| -0.3% | -$2.06M | 0.88% | 20 |
|
|
2022
Q4 | $705M | Sell |
8,216,034
-3,820,541
| -32% | -$303M | 0.99% | 15 |
|
|
2022
Q3 | $743M | Sell |
12,036,575
-3,631,610
| -23% | -$229M | 1.1% | 14 |
|
|
2022
Q2 | $968M | Sell |
15,668,185
-2,334,029
| -13% | -$145M | 1.37% | 10 |
|
|
2022
Q1 | $1.07B | Buy |
18,002,214
+13,764,169
| +325% | +$880M | 1.34% | 7 |
|
|
2021
Q4 | $308M | Buy |
4,238,045
+4,201,326
| +11,442% | +$289M | 0.38% | 61 |
|
|
2021
Q3 | $2.56M | Sell |
36,719
-580,425
| -94% | -$40.8M | ﹤0.01% | 1076 |
|
|
2021
Q2 | $42.5M | Buy |
+617,144
| New | +$41.2M | 0.05% | 366 |
|
|
2021
Q1 | – | Sell |
-3,082,197
| Closed | -$180M | – | 2341 |
|
|
2020
Q4 | $180M | Buy |
3,082,197
+949,275
| +45% | +$57.3M | 0.25% | 70 |
|
|
2020
Q3 | $135M | Buy |
2,132,922
+152,480
| +8% | +$10.6M | 0.21% | 85 |
|
|
2020
Q2 | $152M | Buy |
1,980,442
+881,065
| +80% | +$67.5M | 0.28% | 64 |
|
|
2020
Q1 | $82.2M | Sell |
1,099,377
-690,815
| -39% | -$47.7M | 0.23% | 83 |
|
|
2019
Q4 | $116M | Buy |
1,790,192
+14,088
| +0.8% | +$917K | 0.27% | 74 |
|
|
2019
Q3 | $113M | Sell |
1,776,104
-1,818,029
| -51% | -$119M | 0.26% | 95 |
|
|
2019
Q2 | $243M | Buy |
3,594,133
+341,000
| +10% | +$22.4M | 0.54% | 45 |
|
|
2019
Q1 | $211M | Buy |
3,253,133
+2,073,539
| +176% | +$138M | 0.5% | 40 |
|
|
2018
Q4 | $73.8M | Sell |
1,179,594
-153,107
| -11% | -$10.7M | 0.19% | 123 |
|
|
2018
Q3 | $103M | Sell |
1,332,701
-1,174,582
| -47% | -$88.7M | 0.23% | 103 |
|
|
2018
Q2 | $178M | Sell |
2,507,283
-668,464
| -21% | -$47.2M | 0.43% | 63 |
|
|
2018
Q1 | $239M | Buy |
3,175,747
+105,420
| +3% | +$8.38M | 0.55% | 42 |
|
|
2017
Q4 | $220M | Buy |
3,070,327
+3,046,047
| +12,545% | +$231M | 0.53% | 44 |
|
|
2017
Q3 | $1.97M | Buy |
+24,280
| New | +$1.86M | 0.01% | 707 |
|
|
2017
Q2 | – | Sell |
-864,955
| Closed | -$58.7M | – | 1163 |
|
|
2017
Q1 | $58.7M | Buy |
+864,955
| New | +$60.8M | 0.22% | 120 |
|
|
2016
Q4 | – | Sell |
-14,400
| Closed | -$1.14M | – | 1984 |
|
|
2016
Q3 | $1.14M | Buy |
+14,400
| New | +$1.17M | ﹤0.01% | 1044 |
|
|
2016
Q2 | – | Sell |
-413,300
| Closed | -$38M | – | 1398 |
|
|
2016
Q1 | $38M | Buy |
413,300
+11,500
| +3% | +$1.04M | 0.16% | 145 |
|
|
2015
Q4 | $40.7M | Buy |
401,800
+306,000
| +319% | +$31.8M | 0.19% | 118 |
|
|
2015
Q3 | $9.41M | Buy |
+95,800
| New | +$10.6M | 0.04% | 357 |
|
|
2015
Q1 | – | Sell |
-2,247,420
| Closed | -$212M | – | 1080 |
|
|
2014
Q4 | $212M | Buy |
2,247,420
+107,192
| +5% | +$11.1M | 1.21% | 13 |
|
|
2014
Q3 | $228M | Buy |
2,140,228
+1,807,032
| +542% | +$177M | 1.22% | 13 |
|
|
2014
Q2 | $27.6M | Sell |
333,196
-3,182,295
| -91% | -$248M | 0.14% | 154 |
|
|
2014
Q1 | $249M | Buy |
3,515,491
+383,862
| +12% | +$30.1M | 1.51% | 6 |
|
|
2013
Q4 | $235M | Buy |
3,131,629
+551,307
| +21% | +$38.4M | 1.27% | 7 |
|
|
2013
Q3 | $162M | Buy |
2,580,322
+1,072,859
| +71% | +$64.1M | 1.03% | 20 |
|
|
2013
Q2 | $77.2M | Buy |
+1,507,463
| New | +$78.6M | 0.58% | 49 |
|
Other funds holding GILD
VCM
VPM
Arrowstreet Capital's GILD Position: Q1 2026 in Review
Arrowstreet Capital sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 721,200 shares — an estimated $88.5M sold.
Arrowstreet Capital first reported a position in GILD in Q2 2013 and held it in 45 quarters. The position peaked at $1.07B in Q1 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Arrowstreet Capital reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
- Arrowstreet Capital sold 721,200 Gilead Sciences shares in Q1 2026, an estimated $88.5M.
- Arrowstreet Capital first reported a position in Gilead Sciences in Q2 2013 and held it in 45 quarters.
- Arrowstreet Capital's Gilead Sciences position peaked at $1.07B in Q1 2022.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.